Literature DB >> 31368573

A high-fat diet rich in corn oil induces cardiac fibrosis in rats by activating JAK2/STAT3 and subsequent activation of ANG II/TGF-1β/Smad3 pathway: The role of ROS and IL-6 trans-signaling.

Refaat A Eid1, Mahmoud A Alkhateeb2, Attalla Farag El-Kott3,4, Samy M Eleawa5, Mohamed Samir Ahmed Zaki6,7, Sultan Abdullah Alaboodi8, Abd Al-Rahman Salem Al-Shudiefat9, Hussain Aldera2,10, Nada Mohammad Alnamar11, Mohammed Alassiri2,10, Mohammad A Khalil12.   

Abstract

This study compared the effect of low-fat diet (LFD) and high-fat diet rich in corn oil (HFD-CO) on left ventricular (LV) fibrosis in rats and examined their effect of angiotensin II (ANG II), JAK/STAT, and TGF-1β/smad3 pathways. As compared to LFD which didn't affect any of the measured parameters, HFD-CO-induced type 2 diabetes phenotype and increased LV collagen synthesis. Mechanistically, it increased LV levels of ROS, ANG II, ACE, IL-6, s-IL-6Rα, TGF-β1, Smad-3, and activities of JAK1/2 and STAT1/3. AG490, a JAK2 inhibitor, partially ameliorated these effect while Losartan, an AT1 inhibitor completely abolished collagen synthesis. However, with both treatments, levels of ANG II, IL-6, and s-IL-6Rα, and activity of JAK1/STAT3 remained high, all of which were normalized by co-administration of NAC or IL-6 neutralizing antibody. In conclusion: HFD-CO enhances LV collage synthesis by activation of JAK1/STAT3/ANG II/TGF-1β/smad3 pathway. PRACTICAL APPLICATIONS: We report that chronic consumption of a high-fat diet rich in corn oil (HFD-CO) induces diabetes mellitus phenotype 2 associated with left ventricular (LV) cardiac fibrosis in rats. The findings of this study show that HFD-CO, and through the increasing generation of ROS and IL-6 levels and shedding, could activate LV JAK1/2-STAT1/3  and  renin-angiotensin system (RAS) signaling pathways, thus creating a positive feedback between the two which ultimately leads to activation of TGF-1β/Smad3 fibrotic pathway. Herein, we also report a beneficial effect of the antioxidant, NAC, or IL-6 neutralizing antibody in preventing such adverse effects of such HFD-CO. However, this presents a warning message to the current sudden increase in idiopathic cardiac disorders, especially with the big shift in our diets toward n-6 PUFA.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Angiotensin; JAK/STAT; corn oil; fibrosis; heart; high-fat diet

Year:  2019        PMID: 31368573     DOI: 10.1111/jfbc.12952

Source DB:  PubMed          Journal:  J Food Biochem        ISSN: 0145-8884            Impact factor:   2.720


  9 in total

Review 1.  Basic Mechanisms of Diabetic Heart Disease.

Authors:  Rebecca H Ritchie; E Dale Abel
Journal:  Circ Res       Date:  2020-05-21       Impact factor: 17.367

Review 2.  Remodeling and Fibrosis of the Cardiac Muscle in the Course of Obesity-Pathogenesis and Involvement of the Extracellular Matrix.

Authors:  Jagoda Kruszewska; Agnieszka Cudnoch-Jedrzejewska; Katarzyna Czarzasta
Journal:  Int J Mol Sci       Date:  2022-04-11       Impact factor: 6.208

Review 3.  The Scientific Rationale for the Introduction of Renalase in the Concept of Cardiac Fibrosis.

Authors:  Dijana Stojanovic; Valentina Mitic; Miodrag Stojanovic; Jelena Milenkovic; Aleksandra Ignjatovic; Maja Milojkovic
Journal:  Front Cardiovasc Med       Date:  2022-05-31

4.  Sacubitril/valsartan inhibits obesity-associated diastolic dysfunction through suppression of ventricular-vascular stiffness.

Authors:  Annayya R Aroor; Srinivas Mummidi; Juan Carlos Lopez-Alvarenga; Nitin Das; Javad Habibi; Guanghong Jia; Guido Lastra; Bysani Chandrasekar; Vincent G DeMarco
Journal:  Cardiovasc Diabetol       Date:  2021-04-21       Impact factor: 9.951

5.  PKM2 promotes angiotensin-II-induced cardiac remodelling by activating TGF-β/Smad2/3 and Jak2/Stat3 pathways through oxidative stress.

Authors:  Xiyu Zhang; Cuiting Zheng; Zhenqiang Gao; Lingling Wang; Chen Chen; Yuanyuan Zheng; Yan Meng
Journal:  J Cell Mol Med       Date:  2021-10-23       Impact factor: 5.310

6.  Exendin-4 Protects Against Myocardial Ischemia-Reperfusion Injury by Upregulation of SIRT1 and SIRT3 and Activation of AMPK.

Authors:  Refaat A Eid; Mashael Mohammed Bin-Meferij; Attalla Farag El-Kott; Samy M Eleawa; Mohamed Samir Ahmed Zaki; Mubarak Al-Shraim; Fahmy El-Sayed; Muhammad Alaa Eldeen; Mahmoud A Alkhateeb; Samah A Alharbi; Hussain Aldera; Mohammad A Khalil
Journal:  J Cardiovasc Transl Res       Date:  2020-04-01       Impact factor: 4.132

Review 7.  Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities.

Authors:  Izabela Tuleta; Nikolaos G Frangogiannis
Journal:  Adv Drug Deliv Rev       Date:  2021-07-29       Impact factor: 17.873

Review 8.  Converging pathways in pulmonary fibrosis and Covid-19 - The fibrotic link to disease severity.

Authors:  Jenny Wigén; Anna Löfdahl; Leif Bjermer; Linda Elowsson-Rendin; Gunilla Westergren-Thorsson
Journal:  Respir Med X       Date:  2020-10-09

Review 9.  G Protein-Coupled Receptor Kinase 2 as Novel Therapeutic Target in Fibrotic Diseases.

Authors:  Nan Li; Shan Shan; Xiu-Qin Li; Ting-Ting Chen; Meng Qi; Sheng-Nan Zhang; Zi-Ying Wang; Ling-Ling Zhang; Wei Wei; Wu-Yi Sun
Journal:  Front Immunol       Date:  2022-01-17       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.